Terms: = Ovarian cancer AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306
8 results:
1. External Validation of the ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International ovarian Tumor Analysis 2-Step Strategy to Stratify ovarian Tumors Into O-RADS Risk Groups.
Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
[TBL] [Abstract] [Full Text] [Related]
2. A retrospective analysis of immunohistochemically determined irf4 (interferon regulating factor 4) expression in a consecutive cohort of 114 ovarian cancer patients.
Heimes AS; Schmidt M; Jäkel J; Almstedt K; Gebhard S; Weyer-Eiberich V; Elger T; Krajnak S; Brenner W; Hasenburg A; Battista MJ
Arch Gynecol Obstet; 2019 Jan; 299(1):239-246. PubMed ID: 30357498
[TBL] [Abstract] [Full Text] [Related]
3. Single nucleotide variant in Nucleoporin 107 may be predictive of sensitivity to chemotherapy in patients with ovarian cancer.
Alanee S; Delfino K; Wilber A; Robinson K; Brard L; Semaan A
Pharmacogenet Genomics; 2017 Jul; 27(7):264-269. PubMed ID: 28562428
[TBL] [Abstract] [Full Text] [Related]
4. Hodgkin lymphoma as a novel presentation of familial DICER1 syndrome.
Kuhlen M; Hönscheid A; Schemme J; Merz H; Mauz-Körholz C; Borkhardt A; Troeger A
Eur J Pediatr; 2016 Apr; 175(4):593-7. PubMed ID: 26526666
[TBL] [Abstract] [Full Text] [Related]
5. Diffuse large B-cell lymphoma occurring in an ovarian cystic teratoma: expanding the spectrum of large B-cell lymphoma associated with chronic inflammation.
Valli R; Froio E; Alvarez de Celis MI; Mandato VD; Piana S
Hum Pathol; 2014 Dec; 45(12):2507-11. PubMed ID: 25439346
[TBL] [Abstract] [Full Text] [Related]
6. Imaging in gynecological disease (9): clinical and ultrasound characteristics of tubal cancer.
Ludovisi M; De Blasis I; Virgilio B; Fischerova D; Franchi D; Pascual MA; Savelli L; Epstein E; Van Holsbeke C; Guerriero S; Czekierdowski A; Zannoni G; Scambia G; Jurkovic D; Rossi A; Timmerman D; Valentin L; Testa AC
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):328-35. PubMed ID: 23893713
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroups.
Ozsan N; Bedke BJ; Law ME; Inwards DJ; Ketterling RP; Knudson RA; Keeney GL; Dogan A; Feldman AL
Am J Surg Pathol; 2011 Nov; 35(11):1691-9. PubMed ID: 21997689
[TBL] [Abstract] [Full Text] [Related]
8. Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
Sundram U; Harvell JD; Rouse RV; Natkunam Y
Mod Pathol; 2003 Aug; 16(8):802-10. PubMed ID: 12920225
[TBL] [Abstract] [Full Text] [Related]
